References
- Gladstone DJ, Black SE. Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier?. Can J Neurol Sci 2000; 27: 97–105
- Feeney DM, Weisend MP, Kline AE. Noradrenergic pharmacotherapy, intracerebral infusion and adrenal transplantation promote functional recovery after cortical damage. J Neural Transplant Plast 1993; 4: 199–213
- Crisostomo EA, Duncan PW, Propst M, Dawson DV, Davis JN. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 1988; 23: 94–97
- Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke 1995; 26: 2254–2259
- Walker-Batson D, Curtis S, Natarajan R, Ford J, Dronkers N, Salmeron E. A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke 2001; 32: 2093–2098
- Sonde L, Nordstrom M, Nilsson CG, Lokk J, Viitanen M. A double-blind placebo-controlled study of the effects of amphetamine and physiotherapy after stroke. Cerebrovasc Dis 2001; 12: 253–257
- Treig T, Werner C, Sachse M, Hesse S. No benefit from D-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study. Clin Rehabil 2003; 17: 590–599
- Martinsson L, Wahlgren NG, Hardemark HG. Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev 2003, 3, CD002090
- Scheidtmann K, Fries W, Muller F, Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 2001; 358: 787–790
- Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B. Methylphenidate in early poststroke recovery: a double-blind, placebo- controlled study. Arch Phys Med Rehabil 1998; 79: 1047–1050
- Greener J, Enderby P, Whurr R. Pharmacological treatment for aphasia following stroke. Cochrane Database Syst Rev 2001, 4, CD000424
- Ricci S, Celani MG, Cantisani AT, Righetti E. Piracetam for acute ischaemic stroke. Cochrane Database Syst Rev 2000, 2, CD000419
- Berthier ML, Hinojosa J, Martin MC, Fernandez I. Open-label study of donepezil in chronic poststroke aphasia. Neurology 2003; 60: 1218–1219
- Berthier ML, Pujol J, Gironell A, Kulisevsky J, Deus J, Hinojosa J. Beneficial effect of donepezil on sensorimotor function after stroke. Am J Phys Med Rehabil 2003; 82: 725–729
- Bragoni M, Altieri M, Di Piero V, Padovani A, Mostardini C, Lenzi GL. Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke. Neurol Sci 2000; 21: 19–22
- Jorge RE, Robinson RG, Arndt S, Starkstein S. Mortality and poststroke depression: a placebo–controlled trial of antidepressants. Am J Psych 2003; 160: 1823–1829
- Gonzalez-Torrecillas JL, Mendlewicz J, Lobo A. Effects of early treatment of poststroke depression on neuropsychological rehabilitation. Int Psychogeriatr 1995; 7: 547–560
- Gainotti G, Antonucci G, Marra C, Paolucci S. Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psych 2001; 71: 258–261
- Paolucci S, Antonucci G, Grasso MG, Morelli D, Troisi E, Coiro P. Post-stroke depression, antidepressant treatment and rehabilitation results: a case-control study. Cerebrovasc Dis 2001; 12: 264–271
- Dam M, Tonin P, De Boni A, Pizzolato G, Casson S, Ermani M. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996; 27: 1211–1214
- Pariente J, Loubinoux I, Carel C, Albucher JF, Leger A, Manelfe C. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 2001; 50: 718–729
- Goldstein LB. Potential effects of common drugs on stroke recovery. Arch Neurol 1998; 55: 454–456
- Troisi E, Paolucci S, Silvestrini M, Matteis M, Vernieri F, Grasso MG. Prognostic factors in stroke rehabilitation: the possible role of pharmacological treatment. Acta Neurol Scand 2002; 105: 100–106